Tacrolimus, a new treatment to atopic dermatitis: An observational pilot study in routine clinical practice;Tacrolimus como tratamiento de la dermatitis atópica: Estudio piloto observacional en la práctica clínica

Alergologia e Inmunologia Clinica

Volumn 18, Issue 6, 2003, Pages 269-273

  Gonzalez De Olano D ^a   Roan Roan, J ^a   De La Hoz Caballer, B ^a   Amaruch Garcia N ^a   Moral Jimenez S ^a   Muriel, A ^a   Sanchez Cano M ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Atopic dermatitis; Clinical practice; Corticosteroids resistance; Observational; SCORAD index; Tacrolimus

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CLINICAL PRACTICE; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MALE; PILOT STUDY; PRURITUS; SIDE EFFECT; SKIN BURNING SENSATION; TREATMENT OUTCOME;

EID: 0346102753     PISSN: 1575734X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hanifin JM, Rajka G. Diagnosis features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980; 92: 44-47.
2. Fleischer AB JR. Treatment of atopic dermatitis: role of tacrolimus ointment topical noncorticosteroidal therapy. J Allergy Clin Immunol 1999; 104(3 Pt 2): S126-30.
3. Reitamo S, Van Leent EJ, Ho V, Harper J, Ruzicka T, Kalimo K, et al. Efficacy and safety of tacrolimus ointment compared with the hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol 2002; 109: 401-403.
4. Reitamo S, Van Leent EJ, Ho V, Harper J, Ruzicka T, Kalimo K, et al. Efficacy and safety of tacrolimus ointment compared with the hydrocortisone butyrate ointment in adult with atopic dermatitis. J Allergy Clin Immunol 2002; 109: 547-555.
5. Ortiz de Frutos FJ. New horizons in the treatment of atopic dermatitis. Allergol Immunopathol (Madr) 2002; 30: 134-140.
6. Ruzick T, Bieber T, Schopf E, Rubins A, Dobozy A, Bos JD, et al. A short-term trial of tacrolimues ointment for atopic dermatitis European Tacrolimus Multicenter Atopic Dermatitis Study. N Engl J Med 1997; 337: 1788-1789.
7. Boguniewcz M, Fiedler VC, Raimer S, Lawrence ID, Leung DY. A randomized, vehicle-controlled trial of tacrolimus ointment treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. J Allergy Clin Immunol 1998; 102(4 Pt 1): 637-644.
8. Hanifin JM, Ling MR, Langley R, Breneman D, Rafal E. Tacrolimus ointment for the treatment of atopic dermatitis in patients: part I, efficacy. J Am Acad Dermatol 2001; 44(1 Suppl): S28-38.
9. Soter NA, Fleischer AB JR, Webster GF, Monroe E, Lawrence I. Tacrolimus ointment for the treatment of atopic dermatitis in patients: part II, safety. J Am Acad Dermatol 2001; 44(1 Suppl): 39-46.
10. Paller A, Eichenfield LF, Leung DY, Stewart D, Appell M. A 12-week study of tacrolimus ointment for the treatment of dermatitis in pediatric patients. J Am Acad Dermatol 2001; 44(1 Suppl): S47-57.
11. Drake L, Prendergast M, Maher R, Breneman D, Korman N, Satoi Beusterien KM, et al. The impact of tacrolimus ointment on health-related quality adult and pediatric patients with atopic dermatitis. J Am Acad Dermatol 2001; 44(1 Suppl): S65-72.
12. Cheer SM, Plosker GL. Tacrolimus ointment. A review of its therapeutic potencial as topical therapy in atopic dermatitis. Am J Clin Dermatol 2001; 2: 389-406.
13. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis; the SCORAD index. Dermatology 1993; 186: 23-31.
14. Monografía de Alergia Cutánea de la Sociedad Española de Alergología e Inmunología, Grupo SANED, capítulo 8, pág 118-120.